Correction: Choi et al. Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment 18F-FDG-PET/CT in Patients with Laryngeal Cancer and Hypopharyngeal Cancer. J. Pers. Med. 2024, 14, 71.
Joon Ho Choi, Joon Young Choi, Sang-Keun Woo, Ji Eun Moon, Chae Hong Lim, Soo Bin Park, Seongho Seo, Yong Chan Ahn, Myung-Ju Ahn, Seung Hwan Moon, Jung Mi Park
{"title":"Correction: Choi et al. Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment <sup>18</sup>F-FDG-PET/CT in Patients with Laryngeal Cancer and Hypopharyngeal Cancer. <i>J. Pers. Med.</i> 2024, <i>14</i>, 71.","authors":"Joon Ho Choi, Joon Young Choi, Sang-Keun Woo, Ji Eun Moon, Chae Hong Lim, Soo Bin Park, Seongho Seo, Yong Chan Ahn, Myung-Ju Ahn, Seung Hwan Moon, Jung Mi Park","doi":"10.3390/jpm15020074","DOIUrl":null,"url":null,"abstract":"<p><p>In the original publication [...].</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 2","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856748/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15020074","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
期刊介绍：
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
